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Introduction
Feticide was first used for reduction of multifetal preg-
nancies in the 1980s, to improve pregnancy outcome
and reduce the risk of prematurity. Studies by Evans 
et al [1] and Dumez and Oury [2] described a surgical
approach to improve the outcome in such cases.
Under certain circumstances such as fetal abnormalities,
this procedure could be used for the termination of
singleton pregnancies, as initiated during the early to
mid-1990s in the United Kingdom. Late termination of
pregnancy (LTOP) is defined as termination at a time
when gestation approaches viability. The minimum ges-
tational age for fetal viability is usually considered to be
between 22 and 24 weeks. To prevent fetal distress, feti-
cide is necessary prior to LTOP. A 1996 Royal College
of Obstetricians and Gynaecologists document sug-
gested that feticide could be performed for gestations
later than 22 weeks, but this was later reinterpreted in
2001: “For all terminations at gestational age of more
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SUMMARY
Objective: Improvements in equipment and diagnostic skills mean that more abnormalities can now be
detected antenatally, thus increasing the demand for pregnancy termination at later stages of gestation.
Potassium chloride injected into the fetal circulation is the most frequently used procedure. In this study, 
we propose a new method of feticide using injection of normal saline into the fetal pericardial space to induce
cardiac tamponade, resulting in late fetal reduction with minimal maternal risk.
Case Report: A 32-year-old, gravida 6, woman was a carrier of a balanced translocation 45,XX,der(2),t(2,22),
and had a poor obstetric history. Chorionic villus sampling was performed, and the results revealed the fetus 
to be a balanced translocation carrier, like the mother. Microcephaly was detected during the third trimester
and amniocentesis was performed. The results showed a 45,XX,der(2)t(2;22)(q37,q11.2)mat,−22 karyotype.
After counseling, the mother elected to undergo pregnancy termination. Feticide was performed before labor
induction. However, she experienced discomfort when a minimal amount of potassium chloride (3 mEq) was
injected into the fetal heart, without inducing fetal asystole. We, therefore, induced cardiac tamponade using
10 mL of normal saline instilled into the fetal pericardial space. Fetal asystole was noted. The whole procedure
was performed without incident, and termination was achieved by hysterotomy after informed consent 
was given.
Conclusion: Many methods of feticide have been used, including injection of potassium chloride, lidocaine,
digoxin or hyperosmolar urea into the fetal circulation. However, these methods all use medications or com-
pounds with some potential for maternal toxicity or side effects. We provide a relatively safe and effective
method of feticide for use in late termination of pregnancy. [Taiwan J Obstet Gynecol 2009;48(2):159–162]
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than 21 weeks and 6 days, the method chosen should
ensure that the fetus is born dead. This should be
undertaken by an appropriately trained practitioner.
Intracardiac potassium chloride is the recommended
method and the dose should ensure that fetal asystole
has been achieved” [3,4].
With improvements in the resolution of ultrasound
examinations, the sophistication of prenatal diagnostic
techniques [5] and an emphasis on eugenics, an increas-
ing number of LTOPs are now performed. Because
LTOP is not legal in some countries, no global statistical
data are available. In Australia, a report in 1995 [6] indi-
cated that pregnancy termination was performed after
the diagnosis of fetal abnormalities in 3 per 1,000 births.
In the United Kingdom, a report in 1994 [7] estimated
the proportions of terminations performed at 20–24
weeks’ gestation and at 25 weeks or above to be 1.2%
and 0.05%, respectively. In Israel, where elective abortion
is allowed up to 24 weeks gestation, 9% of abortions
are performed in the second trimester, and about 1%
in the third trimester [8].
The common practice for feticide involves injecting
potassium chloride into the fetal heart to induce fetal
asystole. However, the risk of maternal toxicity due 
to leakage of potassium chloride into the maternal cir-
culation cannot be eliminated. We describe a new
method of feticide by injection of normal saline into
the fetal pericardial space to induce artificial fetal car-
diac tamponade.
Case Report
A 32-year-old, gravida 6, para 2, abortus 3, woman with
a poor obstetric history was known to be a balanced
translocation carrier [45,XX,der(2),t(2,22)]. Her first
pregnancy ended at 10 weeks owing to intrauterine
fetal demise. Her second pregnancy resulted in a live
birth at 39 weeks’ gestation, but the infant died on the
seventh postnatal day due to complex heart disease. Her
third pregnancy was terminated at 22 weeks’ gestation
because of the detection of an unbalanced transloca-
tion. Chorionic villus sampling (CVS) was performed
during her fourth pregnancy. An unbalanced translo-
cation was again detected in this fetus and the preg-
nancy was terminated at 13 weeks. Her fifth pregnancy
ended at 7 weeks owing to missed abortion, in which
the karyotyping was normal. During the studied preg-
nancy, CVS was performed at 12 weeks’ gestation when
the pregnancy was confirmed. The analysis revealed 
a balanced translocation, the same as in the mother.
The pregnancy was initially considered to be normal,
but the fetus was subsequently found to be small 
for gestational age and microcephaly was detected.
Amniocentesis was performed at 35 weeks’ gestation,
in case the previously detected balanced karyotype
had been caused by maternal contamination during
CVS. Karyotyping of the amniocytes disclosed 45,XX,
der(2)t(2;22)(q37,q11.2)mat,−22. We counseled the
patient and her husband regarding termination with
feticide or the possibility of maintaining the pregnancy
until delivery. They opted for feticide followed by LTOP.
The mother was admitted to our ward for pregnancy
termination at a gestational age of 36 weeks. A very
low dose of potassium chloride (about 1–2 mL) was
initially injected into the fetal heart under ultrasound
guidance. Nevertheless, the patient felt immediate dis-
comfort and fetomaternal circulation communication
was suspected. The procedure was temporarily aborted
until the patient recovered. Feticide was attempted
again, using lidocaine instead of potassium chloride.
However, the patient still experienced discomfort and
the procedure was stopped again. Finally, after send-
ing the patient to an operating theater for close car-
diovascular and ventilatory surveillance, 0.9% sodium
chloride was injected into the fetal pericardial space
(Figure 1) to induce artificial cardiac tamponade
(Figure 2). Fetal heart asystole was eventually con-
firmed. The patient felt no discomfort during this pro-
cedure. The patient then underwent hysterotomy, after
giving informed consent. A female fetus weighing 2,495 g
was delivered. Subsequent tissue chromosome analysis
showed 45,XX,der(2)t(2;22)(q37,q11.2)mat,−22 karyo-
type, which confirmed the results of amniocentesis.
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Figure 1. Procedure for injecting normal saline into the fetal
pericardial space to achieve cardiac tamponade under ultra-
sound surveillance.
Discussion
Potassium chloride injection is the standard procedure
for feticide. It was initially used by injection into the
fetal heart, but this gave rise to concerns about fetal
suffering [9,10]. To prevent potential fetal suffering,
Senat et al [11] reported injecting potassium chloride
into the umbilical vein. This extrafetal injection tech-
nique was reported to be successful in 86.7% of cases
performed at 18–32 weeks’ gestation [12]. The in-
creased maternal volume of distribution and pregnancy-
related physiologic changes both provide protection for
the mother against the systemic toxicity of potassium
chloride, but accidental maternal injection cannot be
completely avoided. In addition, potassium chloride
was reported to hasten tissue autolysis and increase
the difficulty of central nervous system autopsy or
microscopy [12]. Lidocaine injection into the umbili-
cal vein was introduced as an alternative. This drug
was reported to effectively induce fetal asystole and
was thus less dangerous for the mother, because the
amount crossing the placenta would be below the
toxic dose. Even in the event of inadvertent maternal
injection, the dose would still be safe for the mother. 
A success rate of 92% was described for administra-
tion at 20–36 weeks [13]. In the present case, the
patient experienced discomfort despite the minimal
dose of potassium chloride or lidocaine. Other agents
have also been used for induction of fetal asystole,
including digoxin and hyperosmolar urea, administered
intracardially [14]. The various methods of feticide 
reported in the literature are listed in the Table.
Whether or not fetuses are conscious and able to
feel pain is a controversial issue. It has been suggested
that fetuses may have the biological capacity to experi-
ence pain from 24 weeks’ gestation onwards. Some
authors, therefore, proposed that fetal analgesia should
be provided prior to the feticide procedure [15–18]. 
A single umbilical vein puncture and administration of
5 μg of sufentanil prior to feticide with potassium
chloride or lidocaine has been reported [11,13].
Ethical and legal issues often occur during the 
decision-making process leading to feticide. The uncer-
tain prognosis of many fetal disorders or abnormali-
ties sometimes results in the late termination of fetuses
that appeared normal earlier in gestation. However,
late termination challenges the law in many countries.
The gestational threshold was set at 24 weeks in the
1967 Abortion Act in the United Kingdom. However,
since 1991, UK abortion law states that: “a person
shall not be guilty of an offence under the law relating
to an abortion when a pregnancy is terminated by a reg-
istered medical practitioner if two medical practition-
ers are of an opinion formed in good faith that there is
a substantial risk that if the child were born it would
suffer from such physical or mental abnormalities as
to be seriously handicapped” [19]. This breakthrough
made LTOP during the third trimester legal. However,
the laws governing pregnancy termination vary from
country to country. In some European countries such
as France, England, Wales, Belgium, Norway, Sweden
and Finland, there is no gestational limit to termination
under certain circumstances, such as lethal or severe
fetal anomalies. The same attitude is reflected in other
parts of the world, such as Israel, India, Cuba, Canada,
Australia, and a few states in the United States [20].
However, there are no legal regulations governing the
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Figure 2. Artificial pericardial effusion (arrow), lying between
the fetal mediastinum/lungs and the fetal heart.
Table. Previously reported methods of feticide in late termination
Agent Method
Gestational Successful 
age (wk) cases (n)
Isada et al [9] Potassium chloride (2 mEq/mL), 3–5 mL Intracardiac 19–24 20/21
Senat et al [11] Potassium chloride (20%), 10 mL Through umbilical vein 22–38 10/10
Senat et al [13] Lidocaine (1%), 7–30 mL Through umbilical vein 20–36 46/50
Hern et al [14] Digoxin 1.5 mg or hyperosmolar urea Intracardiac 25–34 54/54
upper limit of gestational age for pregnancy termina-
tion in Taiwan, though international guidelines are
usually followed. Thus, LTOP is legal for some condi-
tions, such as lethal or chromosomal abnormalities,
as explained by the Taiwan Association for Obstetrics
and Gynecology [21].
The ethical controversy surrounding LTOP focuses
on the rights of the fetus. Is the fetus a patient? Should
we have the right to deprive them of their live? This
dilemma concerns physicians. Chiang [21], from Taipei
Mackay Memorial Hospital, provided an excellent re-
view of late feticide, including a list of the categories of
abnormalities that could justify feticide, and which
should be strictly followed in this country.
In conclusion, live birth is not allowed in LTOP,
and an effective and safe method of feticide prior to
late termination is, therefore, necessary. Considering
the potential adverse consequences to the mother of
drug mal-injection and cross-circulation between the
maternal–placental compartments during gestation,
we chose to inject normal saline into the fetal pericar-
dial space to induce artificial cardiac tamponade as
an alternative method of feticide associated with mini-
mal maternal risk. Late feticide has been preceded by
fetal analgesia since 2008 in our institution, but fur-
ther studies are required to determine the need for this
procedure.
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